As a result, this subfamily of chemokines has an impact on a variety of lung disorders, ranging from allergic rhinitis to tuberculosis and lung cancer, while impacting critical signaling pathways such as NF-κB, EGFR, and RSK1/2/AKT/ERK. Here, AKT1 is linked to lung carcinoma.